Articles from IQVIA Holdings Inc.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the UBS Healthcare Conference in Rancho Palos Verdes, California on Wednesday, November 13, 2024 at 1:15 p.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today reported financial results for the quarter ended September 30, 2024.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its third-quarter 2024 financial results before the market opens on Thursday, October 31, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Healthcare Conference in New York on Wednesday, September 4, 2024 at 10:00 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2024.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its second-quarter 2024 financial results before the market opens on Monday, July 22, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Bank of America Health Care Conference in Las Vegas on Tuesday, May 14, 2024 at 12:20 p.m. ET (9:20 a.m. local PT).

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2024.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its first-quarter 2024 financial results before the market opens on Thursday, May 2, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Barclays 26th Annual Global Healthcare Conference in Miami on Wednesday, March 13, 2024 at 9:30 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at Citi’s 2024 Unplugged Medtech and Life Sciences Access Day in New York on Thursday, February 29, 2024 at 9:30 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended December 31, 2023.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its fourth-quarter and full-year 2023 financial results before the market opens on Wednesday, February 14, 2024. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Evercore Annual HealthCONx Conference in Miami on Wednesday, November 29, 2023 at 10:50 a.m. ET.

IQVIA Holdings Inc. (NYSEIQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Borrower”), allocated a new term B loan due 2031 of approximately $1,500 million (the “New Term Loan B”), which was upsized due to lender demand.

IQVIA Holdings Inc. (NYSEIQV) (the “Company”) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer” or “Borrower”), priced an offering of $1,250 million in aggregate principal amount of senior secured notes due 2029 (the “Notes”), which was upsized due to strong demand. Substantially concurrently with the closing of this offering, the Borrower intends to amend its senior secured credit facilities (the “Credit Agreement Amendment”) to provide for a new term B loan due 2031 of approximately $1,250 million (the “New Term Loan B”).

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Baird 2023 Global Healthcare Conference in New York City on Wednesday, September 13, 2023 at 10:50 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2023.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its second-quarter 2023 financial results before the market opens on Tuesday, August 1, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (NYSEIQV) today announced that its wholly-owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of $1,250,000,000 in aggregate principal amount of senior notes, which was upsized due to strong demand, consisting of $750,000,000 in aggregate principal amount of senior secured notes due 2028 (the “Senior Secured Notes”) and $500,000,000 in aggregate principal amount of senior notes due 2030 (the “Senior Notes” and, together with the Senior Secured Notes, the “Notes”). The proceeds from the Notes offering will be used to repay existing borrowings under the Issuer’s revolving credit facility and to pay fees and expenses related to the Notes offering.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2023.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its first-quarter 2023 financial results before the market opens on Thursday, April 27, 2023. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended December 31, 2022.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2022.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Credit Suisse Annual Healthcare Conference in Rancho Palos Verdes on Tuesday, November 8, 2022 at 12:10 p.m. ET (9:10 a.m. PT).

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its third-quarter 2022 financial results before the market opens on Wednesday, October 26, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that same day. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Morgan Stanley Annual Global Healthcare Conference in New York City on Tuesday, September 13, 2022 at 11:10 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2022.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its second-quarter 2022 financial results before the market opens on Thursday, July 21, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will speak at the Jefferies Healthcare Conference in New York City on Friday, June 10, 2022 at 11:30 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2022.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its first-quarter 2022 financial results before the market opens on Wednesday, April 27, 2022. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and contract services to the life sciences industry, today announced the appointment of Costa Panagos, to serve as president of its Research & Development Solutions (R&DS) business unit. He is succeeding Richard Staub III, who is retiring after a successful career spanning more than three decades. Mr. Staub will remain with the company as a senior advisor to the CEO and continue supporting business development and client management activities.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended December 31, 2021.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at Citi’s 2022 Virtual Healthcare Conference on Thursday, February 24, 2022 at 11:00 a.m. ET.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) has been named to FORTUNE magazine’s “World’s Most Admired Companies” list for the fifth consecutive year. This year, IQVIA secured the first place ranking in FORTUNE’s Healthcare: Pharmacy and Other Services category with high marks regarding efficient use of corporate assets, management quality, effectiveness in conducting business globally, and long-term investment value.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended September 30, 2021.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), will host an Analyst and Investor Conference in New York City on Tuesday, November 16, 2021. Management will provide an update on the business, with presentations starting at 10:00 a.m. ET and concluding at approximately 12:30 p.m. ET. Registration is required to attend the event.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), announced today that Ron Bruehlman, executive vice president and chief financial officer, will participate in a virtual fireside chat at the Baird 2021 Global Healthcare Conference on Tuesday, September 14, 2021 at 12:15 p.m. EDT.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended June 30, 2021.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its second-quarter 2021 financial results before the market opens on Tuesday, July 27, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV), a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, today reported financial results for the quarter ended March 31, 2021.

IQVIA Holdings Inc. (“IQVIA”) (NYSEIQV) will announce its first-quarter 2021 financial results before the market opens on Thursday, April 22, 2021. The IQVIA management team will also host a conference call and webcast at 9:00 a.m. Eastern Time on that date. The earnings release and accompanying financial information will be posted on the IQVIA Investor Relations website at http://ir.iqvia.com.